Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Aescin (also spelled escin) is a mixture of saponins derived from horse chestnut (Aesculus hippocastanum) seeds. It is widely used in Europe for chronic venous insufficiency (CVI), a condition related to problems with blood flow in the veins, including symptoms such as varicose veins and, by extension, spider veins. The pharmacological effects of aescin include reducing capillary permeability, improving venous tone, and exerting anti-inflammatory actions. These effects theoretically support its use for venous disorders, including spider veins.

Several randomized controlled trials and meta-analyses have demonstrated that horse chestnut seed extract (standardized to contain aescin) can improve symptoms of CVI, such as leg swelling and pain. However, most studies focus on larger varicose veins and general venous insufficiency rather than specifically on spider veins (telangiectasias), which are smaller, superficial blood vessels. Evidence directly supporting the use of aescin for spider veins is limited and often extrapolated from studies on broader venous disorders.

Overall, the scientific justification for aescin in treating spider veins is modest, with indirect evidence from related venous conditions. Thus, the evidence rating is 2 out of 5, reflecting some clinical support for related conditions but a lack of direct, high-quality evidence specifically for spider veins.

More about Aescin
More about Spider Veins

Other ingredients used for Spider Veins

Other health conditions supported by Aescin

Products containing Aescin